Hi all,
I came across this presentation this evening discussing upcoming biomarker tests for neurodegenerate diseases.
A discussion point was relating to NfL, showing a number of diseases had a marked increase in NfL. Given Prof. Classens latest presentation of ATH434 treatment and the significant reduction of NfL compared to those in the biomuse study, it would be incredibly interesting in my view, if ATH434 could be utilised in all these neurodegenate diseases that have elevated NfL readings.
Abit more to look into, such as how exactly is ATH434 causing such a reduction, but also with such a massive reduction is it preserving axon death, which will no doubt be observed in the 201 study.
Anyways, hope you enjoy. P.S. I didnt watch the full hour just the neurofilament light section. I will likely watch it all when time allows.
https://m.youtube.com/watch?v=__ohWnEJuf8
- Forums
- ASX - By Stock
- ATH
- Neurodegenerate biomarker testing
Neurodegenerate biomarker testing
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.401K | 800.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
77 | 110142186 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 150940914 | 62 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
73 | 107892186 | 0.002 |
26 | 140640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 150940914 | 62 |
0.005 | 8746584 | 15 |
0.006 | 19463867 | 16 |
0.007 | 52264874 | 24 |
0.008 | 38120994 | 29 |
Last trade - 10.20am 08/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online